Navigation Links
Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
Date:11/15/2007

ion that may slow the onset of future bacterial resistance. In addition to its utility in CAP, cethromycin is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure. The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any other indication.

About John Bartlett, M.D.

Dr. Bartlett is a Professor of Medicine in the Division of Infectious Diseases at The Johns Hopkins University School of Medicine, Baltimore, Maryland. He received his undergraduate degree at Dartmouth in 1959 and his medical degree at Upstate Medical Center in Syracuse in 1963. His training in internal medicine was done at the Brigham Hospital in Boston and the University of Alabama, after which he received his fellowship training in infectious diseases at UCLA. In 1970, he joined the faculty of UCLA, and then joined the faculty of Tufts University School of Medicine where he served as Associate Chief of Staff for Research at the Boston VA Hospital. In 1980, he moved to Hopkins where he served as Chief of the Infectious Diseases Division at the School for 26 years, stepping down in June of 2006.

Dr. Bartlett is a past president of the Infectious Disease Society of America (IDSA) and an author of the IDSA/ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia. He was an author of "Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America," which was published in Clinical Infectious Diseases in 2006. He has authored over 500 articles and reviews in peer-reviewed journals, more than 280 book chapters, and 67 editions of 18 books. He has also served on editorial boards for 19 medical journals including Infectious Diseases in Clinical Practice (Editor) and Clinical Infectious Diseases Medicine (Associate Editor).

About Donald
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
4. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
5. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
6. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... McGraw-Hill Education Professional, a leading global provider ... medical communities, has announced the launch of the ... the world-renowned medical education platform. A ... available for download onto all iOS and Android devices, ... access to valuable AccessMedicine diagnostic resources in ...
(Date:7/29/2014)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... 2014 financial results after the Nasdaq market closes on ... live conference call and webcast to discuss its financial ... 7, 2014 at 8:00 a.m. Eastern Time (5:00 a.m. ... conference call by dialing 866-952-1907 (US) or 785-424-1826 (International) ...
(Date:7/29/2014)... July 29, 2014 Research and Markets ... Respiratory Devices Market 2014-2018" report to their offering. ... A respiratory device is a medical device used to ... difficulty in breathing and cannot achieve adequate oxygen levels ... cystic fibrosis, asthma, COPD, and ARDS require the need ...
Breaking Medicine Technology:McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2Global Respiratory Devices Market 2014-2018 2
(Date:7/29/2014)... Hopkins researchers say they have discovered a chemical alteration ... that, if confirmed in larger studies, could give doctors ... risk of attempting suicide. , The discovery, described online ... that changes in a gene involved in the function ... significant role in turning what might otherwise be an ...
(Date:7/29/2014)... Diabetes is a common condition diagnosed in millions of people. ... while the production of insulin is decreased. , Insulin ... needed by the body to regulate blood sugar levels. Diabetes ... as there are numerous complications that can be developed by ... read a complex review of Matt Traverso's new book go ...
(Date:7/29/2014)... For numerous women from all over the world, ... out being quite hard. Well, the author of the Make ... that can help all these women. This is the formula ... love and attention every day. , Daily Gossip reveals ... by Alex Carter who published a unique eBook to detail ...
(Date:7/29/2014)... Daily Gossip writes in its Fibroids Miracle review that this ... users how to permanently eliminate uterine fibroids. The system has ... the world. , They have been able to get ... as 12 hours. This means that pain and other disturbing ... Fibroids Miracle review also indicates that the method was developed ...
(Date:7/29/2014)... July 29, 2014 (HealthDay News) -- Want young children ... them something that,s healthy is good for them. Doing ... good, a new study suggests. "Parents and caregivers ... may be better off simply serving the food without ... yummy the food actually is," said study authors Michal ...
Breaking Medicine News(10 mins):Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Reverse Your Diabetes Today Review Exposes Matt Traverso’s New eBook 2Health News:"Make Him Desire You" Review Reveals Unique Formula to Make Men Feel a Special Kind of Love 2Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2Health News:Kids Will Pass on 'Healthy' Foods 2
... The Substance Abuse and,Mental Health Services Administration ... inaugural Science and Service Awards. These awards,recognize ... treat mental illnesses and substance abuse., ... to public sector,organizations and community-based groups and ...
... Collection Donates 100% of Net Profits to The ... Ovarian Cancer Research Fund, ... anniversary of its partnership with The Ovarian Cancer Research,Fund (OCRF) and ... decade, L,Oreal Paris has offered hope to the tens of,thousands of ...
... Sicko Serve as Reminder of Need for Genuine Reform -,Nurses ... ... International Nurses Panel Lauds Guaranteed Healthcare Systems, ... Michael Moore,s Sicko will lead a delegation of several,hundred registered ...
... the pharmacys name or logo rather than instructions on ... in the September 10 issue of the Archives of ... 1.5 million medication errors occur each year in the ... the mistakes. While the Food and Drug Administration has ...
... medications again, study finds , , TUESDAY, Sept. 11 (HealthDay ... chronic health problems such as high blood pressure and ... prescription drug plans, new research shows. , The ... also found that many of those seniors do not ...
... The Innovative Vector Control Consortium (IVCC) has embarked ... year strategy with the launch of the first ... health mosquito control products. The three projects, ... IVCC projects developing improved mosquito control information systems. ...
Cached Medicine News:Health News:SAMHSA Announces First Science and Service Award Winners 2Health News:SAMHSA Announces First Science and Service Award Winners 3Health News:SAMHSA Announces First Science and Service Award Winners 4Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 2Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 3Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 4Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 5Health News:September 11th First Responders Lead Emotional Rally at State Capitol Tuesday 2Health News:Prescription labels geared toward pharmacies, not patients 2Health News:Medicare Spending Caps Cause Seniors to Stop Meds 2Health News:IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 2
... dedicated fluorometer from Berthold Technologies, has ... variety of measurement modes to support ... scanning, dual ratio measurements plus top ... valuable instrument for any researcher using ...
The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates....
... VISUCAM non-mydriatic fundus camera ... simplicity of fundus imaging. ... to set the standard ... features a unique combination ...
Small, compact and versatile, the CLK-4 light source is compatible with all Olympus fiberscopes and is ideal for the vast majority of routine fiber-endoscopic procedures, especially in the out-patien...
Medicine Products: